|The combination of long lead times and regulatory constraint are unique to the pharmaceutical industry. As a result, pharmaceutical companies need partners who are reliable, research and development focused, and innovative.
Simcro has a significant record of partnerships with pharmaceutical companies, often in highly confidential market sensitive projects. Our partners have complete confidence in our ability to operate both professionally and in total confidence.
|As a result, many Simcro projects are engineered from a standing start, without necessarily being constrained by 'traditional' solutions. The revolutionary in-line drench action of the Optiline™ Drencher is a prime example – a delivery method as innovative as the drench it administers.
Our approach is to add value throughout development and often the earlier we are involved, the better. As our clients can attest, we're not afraid to challenge a brief if it improves the result.
|These unique factors have been the difference for the world's largest companies. Novartis, Pfizer, Merial and a number of other global pharmaceutical companies have partnered with Simcro to bring to market uniquely tailored proprietary solutions.